Search Results - "Klumb, Claudete E."

Refine Results
  1. 1

    Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma by Minnicelli, Carolina, Barros, Mário H M, Klumb, Claudete E, Romano, Sérgio O, Zalcberg, Ilana R, Hassan, Rocio

    Published in PloS one (27-09-2012)
    “…Epstein-Barr virus (EBV) is an important environmental factor associated to the development of Burkitt lymphoma (BL) in endemic and intermediate risk regions…”
    Get full text
    Journal Article
  2. 2

    Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients by Vasconcelos, Flavia C., Silva, Karina L., Souza, Paloma Silva de, Silva, Luiz Felipe R., Moellmann‐Coelho, Arthur, Klumb, Claudete E., Maia, Raquel Ciuvalschi

    Published in Cytometry. Part B, Clinical cytometry (01-05-2011)
    “…The involvement of the multidrug resistance (MDR) mediated by ABC transporter proteins P‐glycoprotein (Pgp) and multidrug resistance‐associated protein‐1…”
    Get full text
    Journal Article
  3. 3

    Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma by Gualco, Gabriela, MD, Queiroga, Eduardo M., MD, Weiss, Lawrence M., MD, Klumb, Claudete E.N., MD, Harrington, William J., MD, Bacchi, Carlos E., MD

    Published in Human pathology (01-04-2009)
    “…Summary Burkitt lymphoma is a highly aggressive non-Hodgkin lymphoma with endemic, sporadic, and immunodeficiency-associated clinical variants composed of…”
    Get full text
    Journal Article
  4. 4

    Pediatric lymphomas in Brazil by Gualco, Gabriela, Klumb, Claudete E, Barber, Glen N, Weiss, Lawrence M, Bacchi, Carlos E

    Published in Clinics (São Paulo, Brazil) (01-01-2010)
    “…This study provides the clinical pathological characteristics of 1301 cases of pediatric/adolescent lymphomas in patients from different geographic regions of…”
    Get full text
    Journal Article
  5. 5

    NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains by Lucena, Pedro I., Faget, Douglas V., Pachulec, Emilia, Robaina, Marcela C., Klumb, Claudete E., Robbs, Bruno K., Viola, João P. B.

    Published in Molecular and cellular biology (01-01-2016)
    “…The NFAT (nuclear factor of activated T cells) family of transcription factors is composed of four calcium-responsive proteins (NFAT1 to -4). The NFAT2 (also…”
    Get full text
    Journal Article
  6. 6

    Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas by Machado, Alex S. C., Da Silva Robaina, Marcela C., Magalhães De Rezende, Lidia M., Apa, Alexandre G., Amoêdo, Nívea D., Bacchi, Carlos E., Klumb, Claudete E.

    Published in Leukemia & lymphoma (01-06-2010)
    “…Tumor-derived DNA is elevated in the plasma of patients with cancer. The analysis of circulating DNA may be useful for diagnosis, prognosis evaluation, and…”
    Get full text
    Journal Article
  7. 7

    Burkitt lymphoma/leukaemia transformed from a precursor B cell: clinical and molecular aspects by Hassan, Rocio, Felisbino, Fabricio, Stefanoff, Claudio Gustavo, Pires, Virginia, Klumb, Claudete E., Dobbin, Jane, Seuánez, Héctor N., Renault, Ilana Zalcberg

    Published in European journal of haematology (01-03-2008)
    “…Burkitt lymphoma/leukaemia (BL/L) is a heterogeneous disease with respect to epidemiological patterns and cell origin. The occurrence of BL/L with an immature…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    FREQUENT EXPRESSION OF MUM1/IRF4 IN BURKITT LYMPHOMA by Gualco, Gabriela, Queiroga, Eduardo M., Weiss, Lawrence M., Klumb, Claudete E. N., Harrington, William J., Bacchi, Carlos E.

    Published in Human pathology (13-01-2009)
    “…Burkitt lymphoma (BL) is a highly aggressive non-Hodgkin lymphoma (NHL) with endemic, sporadic and immunodeficiency-associated clinical variants composed of…”
    Get full text
    Journal Article
  11. 11

    Survivin and Smac/DIABLO Protein Expression in Patients with Chronic Myelogenous Leukemia by Reis, Flaviana R.S., Silva, Karina L., Pereira, Debora L., Klumb, Claudete E., Maia, Raquel C.

    Published in Blood (16-11-2006)
    “…Defects in apoptosis contribute to prolonged cell survival, growth factor-independent cell survival, resistance to cytotoxicity and alteration in cell cycle…”
    Get full text
    Journal Article
  12. 12

    Retinoblastoma Related Gene RB2/P130 Are Rarely Mutated in Burkitt's Lymphoma from Brazil by Klumb, Claudete E., Magluta, Eliane P.S., Facion, Roberta S., Rezende, Lidia Maria M., Apa, Alexandre G., Carrico, Maria K., Alonso, Joao F., Maia, Raquel C.

    Published in Blood (16-11-2005)
    “…Human RB2/p130 is a member of the retinoblastoma (Rb) family which also includes the retinoblastoma tumor suppressor gene RB/p105 (RB1) and the retinoblastoma…”
    Get full text
    Journal Article
  13. 13

    Detection of p53 Protein in Leukemic Cells by Flow Cytometry by Cavalcanti, Geraldo B., Magluta, Eliane P.S., Scheiner, Marcos Antonio M., Vasconcelos, Flavia C., Dobbin, Jane A., Klumb, Claudete E., Maia, Raquel C.

    Published in Blood (16-11-2005)
    “…Although the alterations of TP53 gene are rare in malignant hematological disorders, these genetic alterations have strong correlations with unfavorable…”
    Get full text
    Journal Article
  14. 14

    Avaliação dos métodos de detecção das alterações do gene e proteína P53 nas neoplasias linfóides by Klumb, Claudete E., Cavalcanti Júnior, Geraldo B.

    “…A proteína p53 desempenha um papel central na resposta celular que inclui a parada do ciclo celular permitindo o reparo do dano no DNA, ou indução da morte…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Resistência ao tratamento no linfoma de Burkitt: associação com mutações específicas no gene TP53? Treatment resistance in Burkitt's lymphoma: is it associated with specific mutations of the TP53 gene? by Eliane P. S. Magluta, Claudete E. Klumb

    “…O linfoma de Burkitt (LB) surge a partir de uma célula do centro germinativo que perde o controle da proliferação devido à ativação do gene c-myc. A…”
    Get full text
    Journal Article
  19. 19
  20. 20